Allermi inhaled $1.25 million in pre-seed funding for personalized online allergy treatment, per Axios. Lucas Venture Group led the round.
Allermi Raises $1M Pre-Seed
Related Posts
Intelligent Medicine Acquisition Prices Upsized $180M IPO
Intelligent Medicine intends to focus on life science companies that are using artificial intelligence, machine learning and big data to power drug discovery.
Thorne HealthTech Closes $70M IPO
BofA Securities, Cowen and Evercore ISI were lead book-running managers for the offering.
Hospital for Special Surgery Raises $21M to Launch New Company Targeting $380B Musculoskeletal Health Sector
The round was led by Flare Capital and HSS.
Element5 Raises $15M Series A
Element5 will use the financing to accelerate growth of their post-acute care solution.